Search Results 241-250 of 14879 for alt

1. Phase III Study Of Datopotamab Deruxtecan Versus Docetaxel In Previously Treated TROP2-positive Advanced Non-squamous NSCLC Without AGA - Mayo Clinic

   Except in the setting of HBV, ALT and AST ≤ 2.5 × ULN; for participants with hepatic metastases, ALT and AST ≤ 5 × ULN. See Exclusion Criterion 10 for ...

2. A Study Of CGM In GBM - Mayo Clinic

   AST and ALT ≤2.5 × ULN. Total bilirubin ≤1.5 × ULN. Willingness and ability to comply with CGM device use and attend dietary counseling sessions as part of ...

3. Statins and CPAP in Adipose Tissue of OSA - Mayo Clinic

   Elevated ALT (> 3 times upper normal limit). Fasting glucose > 120 mg/dL and/or HbA1c ≥ 6.5%. Females planning to be pregnant in next six months. Known ...

4. A Study of Poziotinib in Patients with NSCLC With EGFR or HER2 Exon 20 Insertion Mutation - Mayo Clinic

   SGOT (AST) and SGPT (ALT) ≤ 2.5×ULN with the following exception; Patients with liver metastases AST, ALT ≤ 5×ULN;; Creatinine clearance ≥ 50 mL/min ...

5. Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or Oxaliplatin - Mayo Clinic

   Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) < 3 x the upper limit of normal; Triglycerides < 500 mg/dL; Alkaline phosphatase =< 3 x the ...

6. PKCι & mTOR Inhibition With Auranofin+Sirolimus for Squamous Cell Lung Cancer - Mayo Clinic

   ... [ALT]) ≤ 3 x ULN or SGOT (AST) and SGPT (ALT) ≤ 5 x ULN is acceptable if liver has tumor involvement; Eastern Cooperative Oncology Group (ECOG) performance ...

7. Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia - Mayo Clinic

   Participation eligibility · Serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) <2.5 x institutional upper limit normal (ULN) · Total serum ...

8. A Study of Pembrolizumab (MK-3475) Versus Placebo in Combination with Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer - Mayo Clinic

   Abbreviations: ALT = alanine aminotransferase; AST = aspartate aminotransferase; CrCl = creatinine clearance; GFR = glomerular filtration rate; INR ...

9. MEDI5395 Advanced Solid Tumors - Clinical Trials

   Hepatic ALT ≤ 2.5 × ULN;; AST ≤ 2.5 × ULN;; TBL ≤ 1.5 × ULN [≤ 3 × ULN if the subject has documented Gilbert's syndrome];; Albumin ≥ 3 g/dL;; Renal ...

10. A Study of the Effect of Ixazomib on the Reservoir of T Cells Infected with HIV DNA - Mayo Clinic

    ALT <1.5 x ULN; Creatinine <2.0 x ULN and an estimated creatinine clearance > 60 ml/min. HIV infection with suppressed viral replication on at least 3 active ...